MedTrace Logo

Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer

NCT06314568 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 278

Last updated 2025-08-15

No results posted yet for this study

Summary

Prospective observational multicenter study, aimed at evaluating the effectiveness on local control and cancer-specific survival of radiochemotherapy followed by interventional radiotherapy in patients affected by vaginal cancer

Conditions

  • Vaginal Cancer

Interventions

RADIATION

Radiochemotherapy plus interventional radiotherapy

All patients with vaginal cancer will undergo radiochemotherapy (45 Gy on pelvis and tumor in association with cisplatinum) plus interventional radiotherapy (28 Gy on residual disease) with exclusive intent

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • VALENTINA LANCELLOTTA · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2026-03-31
Completion
2028-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06314568 on ClinicalTrials.gov